TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 58 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $180,000 | -72.6% | 200,000 | -71.4% | 0.00% | -66.7% |
| Q3 2018 | $657,000 | +0.9% | 700,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $651,000 | -82.3% | 700,000 | -80.0% | 0.01% | -94.3% |
| Q4 2013 | $3,680,000 | -35.7% | 3,500,000 | -36.4% | 0.10% | -40.3% |
| Q3 2013 | $5,722,000 | -1.3% | 5,500,000 | 0.0% | 0.18% | +0.6% |
| Q2 2013 | $5,797,000 | +1.3% | 5,500,000 | 0.0% | 0.18% | -19.4% |
| Q1 2013 | $5,720,000 | +2.4% | 5,500,000 | 0.0% | 0.22% | -26.9% |
| Q4 2012 | $5,588,000 | -5.1% | 5,500,000 | 0.0% | 0.30% | -32.3% |
| Q3 2012 | $5,887,000 | +2.5% | 5,500,000 | 0.0% | 0.44% | -12.0% |
| Q2 2012 | $5,742,000 | -4.0% | 5,500,000 | 0.0% | 0.50% | -19.0% |
| Q1 2012 | $5,984,000 | +4.9% | 5,500,000 | 0.0% | 0.62% | -29.8% |
| Q4 2011 | $5,705,000 | +1.7% | 5,500,000 | 0.0% | 0.88% | -13.3% |
| Q3 2011 | $5,612,000 | – | 5,500,000 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 20,000,000 | $17,675,000 | 25.38% |
| INCOME RESEARCH & MANAGEMENT | 23,109,000 | $20,278,000 | 5.29% |
| Fore Capital, LLC | 5,000,000 | $4,430,000 | 1.71% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 20,000,000 | $17,603,000 | 0.74% |
| ARISTEIA CAPITAL, L.L.C. | 18,500,000 | $16,361,000 | 0.70% |
| ZAZOVE ASSOCIATES LLC | 11,153,000 | $9,843,000 | 0.58% |
| BASSO CAPITAL MANAGEMENT, L.P. | 3,600,000 | $3,182,000 | 0.52% |
| CSS LLC/IL | 10,450,000 | $9,240,000 | 0.45% |
| Lombard Odier Asset Management (Europe) Ltd | 7,950,000 | $7,038,000 | 0.44% |
| Wellesley Asset Management | 6,740 | $5,948,000 | 0.31% |